Risk-Tolerant Investors Should Take A Chance On Novavax, Inc. (NASDAQ: NVAX)

NOVA

During the last session, Novavax, Inc. (NASDAQ:NVAX)’s traded shares were 4.71 million, with the beta value of the company hitting 1.97. At the end of the trading day, the stock’s price was $12.83, reflecting an intraday loss of -2.14% or -$0.28. The 52-week high for the NVAX share is $23.86, that puts it down -85.97 from that peak though still a striking 72.49% gain since the share price plummeted to a 52-week low of $3.53. The company’s market capitalization is $1.80B, and the average trade volume was 15.64 million shares over the past three months.

Novavax, Inc. (NASDAQ:NVAX) trade information

Novavax, Inc. (NVAX) registered a -2.14% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -2.14% in intraday trading to $12.83, hitting a weekly high. The stock’s 5-day price performance is -8.75%, and it has moved by -17.31% in 30 days. Based on these gigs, the overall price performance for the year is 81.21%.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Novavax, Inc. (NVAX) estimates and forecasts

Statistics show that Novavax, Inc. has outperformed its competitors in share price, compared to the industry in which it operates. Novavax, Inc. (NVAX) shares have gone up 154.06% during the last six months, with a year-to-date growth rate more than the industry average at 109.06% against 15.50.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 11.55%. While earnings are projected to return 107.92% in 2024, the next five years will return 37.90% per annum.

NVAX Dividends

Novavax, Inc. is due to release its next quarterly earnings in July. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Novavax, Inc. (NASDAQ:NVAX)’s Major holders